Evolving Regulations and Guidelines in Genetic Testing
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.